ArticleCancers2024

The RAGE Inhibitor TTP488 (Azeliragon) Demonstrates Anti-Tumor Activity and Enhances the Efficacy of Radiation Therapy in Pancreatic Cancer Cell Lines.

Kumari Alka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.